Drug Type Small molecule drug |
Synonyms Ilmofosine (USAN/INN), BM 41440, BM-41440 |
Target |
Action inhibitors |
Mechanism PKC inhibitors(Protein kinase C inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC26H56NO5PS |
InChIKeyODEDPKNSRBCSDO-UHFFFAOYSA-N |
CAS Registry83519-04-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D04504 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 2 | Germany | - | - |
Non-Small Cell Lung Cancer | Phase 2 | United States | - | - |
Non-Small Cell Lung Cancer | Phase 2 | - | - |